These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9925380)

  • 1. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
    Kitakaze M; Node K; Minamino T; Asanuma H; Ueda Y; Kosaka H; Kuzuya T; Hori M
    J Mol Cell Cardiol; 1998 Nov; 30(11):2461-6. PubMed ID: 9925380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.
    Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Mori H; Kosaka H; Inoue M; Hori M; Kamada T
    Circulation; 1995 Aug; 92(4):950-61. PubMed ID: 7641379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
    Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M
    J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
    Node K; Kitakaze M; Kosaka H; Minamino T; Mori H; Hori M
    Hypertension; 1998 Jun; 31(6):1290-8. PubMed ID: 9622144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide.
    Kitakaze M; Node K; Takashima S; Minamino T; Kuzuya T; Hori M
    Hypertens Res; 2000 May; 23(3):253-9. PubMed ID: 10821135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs.
    Kitakaze M; Node K; Minamino T; Kosaka H; Shinozaki Y; Mori H; Inoue M; Hori M; Kamada T
    J Am Coll Cardiol; 1996 Jun; 27(7):1804-12. PubMed ID: 8636571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
    J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Force-length relationship in dogs as a measure of protective effect of imidapril on regional myocardial ischemia and reperfusion injury.
    Hosoya K; Takeda K; Nishikimi T; Ishimitsu T; Matsuoka H
    Eur J Pharmacol; 2000 Feb; 390(1-2):157-66. PubMed ID: 10708719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-arginine on metabolic recovery of the ischemic myocardium.
    Carrier M; Khalil A; Tourigny A; Solymoss BC; Pelletier LC
    Ann Thorac Surg; 1996 Jun; 61(6):1651-7. PubMed ID: 8651764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo.
    Matsuda H; Hayashi K; Wakino S; Kubota E; Honda M; Tokuyama H; Takamatsu I; Tatematsu S; Saruta T
    Hypertension; 2004 Mar; 43(3):603-9. PubMed ID: 14769805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
    Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
    J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation].
    Zhang XH; Ma XJ; Luo J; Shao JH; Geng QX; Zhu XL; Tang YS; Xu FY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):592-5. PubMed ID: 15144597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.